Open Access

Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells

  • Authors:
    • Jinhua Yan
    • Ling Yao
    • Ping Li
    • Guohe Wu
    • Xiaobin Lv
  • View Affiliations

  • Published online on: November 18, 2021     https://doi.org/10.3892/ol.2021.13142
  • Article Number: 24
  • Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Long non‑coding (lnc)RNA MIR17HG has been identified as a oncogene whose roles in acute myeloid leukemia (AML) remain unclear. The present study aimed to investigate the role of lncRNA MIR17HG in AML. Differential expression of MIR17HG in AML was determined by reverse transcription‑quantitative PCR. Overexpression assays and dual luciferase reporter assays were performed to determine the relationship between MIR17HG and microRNA (miR)‑21, and apoptosis was analyzed by using an apoptosis assay. The results showed that the expression of MIR17HG was decreased in AML, which was further decreased following homoharringtonine (HHT)‑based chemotherapy. Bioinformatics analysis predicted that miR‑21 could bind with MIR17HG. However, miR‑21 overexpression had no effect on the expression level of MIR17HG. Dual luciferase reporter assays were performed to verify the direct interaction between miR‑21 and MIR17HG. In addition, overexpression of MIR17HG and miR‑21 in AML cell lines up‑ and downregulated the expression level of PTEN, respectively. Furthermore, cell apoptosis showed that MIR17HG and PTEN overexpression enhanced cell apoptosis following cell treatment with HTT. However, miR‑21 overexpression exerted the opposite effect, since it reversed the effects of MIR17HG and PTEN overexpression in AML cell apoptosis. In conclusion, the current study suggested that MIR17HG could regulate the miR‑21/PTEN axis to modulate the chemoresistance of AML cells.
View Figures
View References

Related Articles

Journal Cover

January-2022
Volume 23 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yan J, Yao L, Li P, Wu G and Lv X: Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells. Oncol Lett 23: 24, 2022
APA
Yan, J., Yao, L., Li, P., Wu, G., & Lv, X. (2022). Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells. Oncology Letters, 23, 24. https://doi.org/10.3892/ol.2021.13142
MLA
Yan, J., Yao, L., Li, P., Wu, G., Lv, X."Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells". Oncology Letters 23.1 (2022): 24.
Chicago
Yan, J., Yao, L., Li, P., Wu, G., Lv, X."Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells". Oncology Letters 23, no. 1 (2022): 24. https://doi.org/10.3892/ol.2021.13142